PTC Therapeutics (PTCT) PT Raised to $95 at Wells Fargo

May 8, 2026 6:56 AM

Wells Fargo analyst Ben Burnett raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $95.00 (from $86.00) while maintaining a Overweight rating.

No results found